Michael Born is a Technical Development Senior Principal Scientist at Genentech since 2025. They previously worked as a Scientist in Analytical and Formulations Development at InhibRx from 2017 to 2022 and held the position of Principal Scientist-CMC Analytical at Poseida Therapeutics, Inc. from 2024 to 2025. Earlier in their career, Michael served as an Associate Scientist in Analytical Chemistry at La Jolla Biologics, Inc., and was a Research Investigator at San Diego State University from 2008 to 2009. They began their academic journey as a Graduate Student at Northwestern University from 2011 to 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices